Shares of HDB Financial Services, the non-banking finance arm of HDFC Bank, are all set to make their stock market debut on July 2, 2025. Investors and market watchers are keenly awaiting whether the listing will see a premium opening. Robust Subscription Demand The ₹12,500 crore IPO attracted strong interest, closing with a subscription of 16.69 times on the final day of bidding last Friday. Institutional buyers played a major role in driving demand. IPO
Read More
OPEC+ Ramps Up Output Oil prices remain under pressure as traders digest OPEC+’s latest move to boost supply. The group plans to increase production by 411,000 barrels per day (bpd) in August, bringing total 2025 additions to 1.78 million bpd—more than 1.5% of global oil demand. This fresh wave of supply comes just as global trade uncertainty and slowing economic growth weigh on demand expectations. Brent crude briefly surged past $80 per barrel amid geopolitical
Read More
Indian equities remained volatile throughout Tuesday’s session, with the Nifty 50 oscillating between 25,520 and 25,255. The Sensex, which at one point rose over 200 points, ended with a modest gain of 91 points at 83,697. The Nifty settled 29 points higher at 25,546. Broader markets underperformed, with the Midcap and Smallcap indices snapping their recent winning streaks. The Midcap index slipped 23 points to close at 59,719, ending a seven-day rally. Among key movers,
Read More
On July 1, 2025, aviation turbine fuel (ATF) prices were sharply raised by 7.5%, ending a three-month streak of reductions. According to state-owned fuel retailers, ATF now costs ₹89,344.05 per kilolitre in Delhi after an increase of ₹6,271.5 per kl. This hike effectively reverses about half of the total price cuts implemented between April and June. Previously, ATF rates were lowered by: ₹2,414.25 per kl (2.82%) on June 1 ₹3,954.38 per kl (4.4%) on May
Read More
Motilal Oswal has maintained its “Neutral” rating on Torrent Pharmaceuticals, setting a price target of ₹3,430, which implies modest upside of around 3% from current levels. The brokerage’s stance reflects both the strategic potential and execution risks linked to Torrent’s ambitious plan to acquire JB Chemicals & Pharmaceuticals (JBCP). Here’s a closer look at what’s driving this cautious optimism: Portfolio Expansion Brings Growth—and Challenges The acquisition would give Torrent access to JBCP’s fast-growing domestic formulation
Read More